Current through Register Vol. 6, March 22, 2024
(1)
The board shall register a person to manufacture dangerous drugs (as defined in
50-32-101,
MCA) included in Schedules I through V upon the following conditions:
(a) applicant is registered for such purposes
pursuant to the Federal Controlled Substances Act of 1970;
(b) the applicant has made proper application
and has paid the applicable fee; and
(c) the category of manufacturer as
above-stated shall include only those applicants who are engaged in the
manufacturing of dangerous drugs within the state of Montana.
(2) The board shall register a
person or entity to distribute dangerous drugs included in Schedules I through
V under the following conditions:
(a)
applicant is registered for such purpose pursuant to the Federal Controlled
Substances Act of 1970;
(b) the
applicant has made proper application and paid the applicable fee;
(c) the category of distributor as
above-stated shall include any person or entity who distributes dangerous drugs
or samples thereof within the state of Montana and may include a manufacturer
not otherwise required to be registered if such manufacturer also distributes
dangerous drugs or samples thereof within the state of Montana; and
(d) representatives of drug manufacturers who
distribute controlled substance samples to licensed practitioners shall be
exempt from the requirement of registration.
(3) The board shall register a person to
analyze or conduct research with narcotic dangerous drugs in Schedules II
through V upon making proper application and paying the applicable
fee.
(4) The board shall register a
person to analyze or conduct research with dangerous drugs in Schedule I, if:
(a) the applicant is a practitioner licensed
under the laws of this state;
(b)
the applicant has furnished the board evidence of registration for such purpose
pursuant to the Federal Controlled Substances Act of 1970;
(c) the applicant has furnished the board a
complete resume of all research proposed relative to any dangerous drugs. Such
resume must be a duplicate of an application submitted to the DEA;
and
(d) the applicant has made
proper application and paid the applicable fee.
50-32-103,
MCA; IMP,
50-32-306,
50-32-308,
MCA;
